Research graph
References from VirPLM: antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model. Local targets link to admitted publications; unresolved targets remain external evidence.
The biology of influenza viruses
10.1016/j.vaccine.2008.07.039 · 2008 · External reference
Antigenic distance measurements for seasonal influenza vaccine selection
10.1016/j.vaccine.2011.10.051 · 2012 · External reference
Early prediction of antigenic transitions for influenza a/h3n2
10.1371/journal.pcbi.1007683 · 2020 · External reference
Cost-effectiveness of influenza vaccination strategies in adults: older adults aged ≥ 65 years, adults aged 50–64 years, and at-risk adults aged 19–64 years
10.3390/vaccines10030445 · 2022 · External reference
Effects of influenza vaccination in the United States during the 2018–2019 influenza season
10.1093/cid/ciz1244 · 2020 · External reference
Mapping of h3n2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation
10.1038/ncomms1710 · 2012 · External reference
Fluattn: antigenicity prediction of influenza a/h3n2 through attention-based feature mining
10.1016/j.idm.2025.11.005 · 2026 · External reference
Antigenic assessment of the h3n2 component of the 2019–2020 Northern hemisphere influenza vaccine
10.1038/s41467-020-16183-y · 2020 · External reference
Quantifying influenza vaccine efficacy and antigenic distance
10.1016/j.vaccine.2006.01.010 · 2006 · External reference
Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza a/h3n2 evolution
10.7554/elife.60067 · 2020 · External reference
Insights into the antigenic advancement of influenza a (h3n2) viruses, 2011–2018
10.1038/s41598-019-39276-1 · 2019 · External reference
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution
10.1126/science.1244730 · 2013 · External reference
Antigenicity prediction and vaccine recommendation of human influenza virus a (h3n2) using convolutional neural networks
10.1080/21645515.2020.1734397 · 2020 · External reference
Predicting antigenic variants of influenza a/h3n2 viruses
10.3201/eid1008.040107 · 2004 · External reference
Epistasis mediates the evolution of the receptor binding mode in recent human h3n2 hemagglutinin
10.1038/s41467-024-49487-4 · 2024 · External reference
A sequence-based machine learning model for predicting antigenic distance for h3n2 influenza virus
10.3389/fmicb.2024.1345794 · 2024 · External reference
Flunexus: a versatile web platform for antigenic prediction and visualization of influenza a viruses
10.1002/imt2.70127 · 2026 · External reference
Evolutionary-scale prediction of atomic-level protein structure with a language model
10.1126/science.ade2574 · 2023 · External reference
10.1101/2025.10.29.684974
10.1101/2025.10.29.684974 · External reference
Graph contrastive learning with positional embeddings for predicting influenza antigenicity
10.1016/j.ins.2025.122955 · 2025 · External reference
Predac-cnn: predicting antigenic clusters of seasonal influenza a viruses with convolutional neural network
10.1093/bib/bbae033 · 2024 · External reference
10.1007/978-1-4939-0758-8_2
10.1007/978-1-4939-0758-8_2 · External reference
The challenges of vaccine strain selection
10.7554/elife.62955 · 2020 · External reference
The evolution of seasonal influenza viruses
10.1038/nrmicro.2017.118 · 2018 · External reference
Immunodominance of antigenic site b over site a of hemagglutinin of recent h3n2 influenza viruses
10.1371/journal.pone.0041895 · 2012 · External reference
Effects of influenza vaccination in the United States during the 2017–2018 influenza season
10.1093/cid/ciz075 · 2019 · External reference
10.1038/s41467-024-47862-9
10.1038/s41467-024-47862-9 · External reference
10.1073/pnas.0701396104
10.1073/pnas.0701396104 · External reference
Gisaid: global initiative on sharing all influenza data–from vision to reality
10.2807/1560-7917.es.2017.22.13.30494 · 2017 · External reference
A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season
10.1093/cid/ciw176 · 2016 · External reference
Variable efficacy of repeated annual influenza vaccination
10.1073/pnas.96.24.14001 · 1999 · External reference
Mapping the antigenic and genetic evolution of influenza virus
10.1126/science.1097211 · 2004 · External reference
Effectiveness and cost-effectiveness of influenza vaccination for elderly people
10.1016/j.vaccine.2021.09.054 · 2021 · External reference
Selecting vaccine strains for h3n2 human influenza a virus
10.1016/j.mgene.2015.03.003 · 2015 · External reference
Effect of antigenic drift on influenza vaccine effectiveness in the United States—2019–2020
10.1093/cid/ciaa1884 · 2021 · External reference
Unresolved reference
2025 · External reference
Host defenses against influenza virus: the role of anti-hemagglutinin antibody
10.4049/jimmunol.115.2.434 · 1975 · External reference
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation
10.1038/289373a0 · 1981 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2023 · External reference
Recommended composition of influenza virus vaccines for use in the 2024–2025 northern hemisphere influenza season
2024 · External reference
A structural explanation for the low effectiveness of the seasonal influenza h3n2 vaccine
10.1371/journal.ppat.1006682 · 2017 · External reference
10.1093/cid/ciw635
10.1093/cid/ciw635 · External reference
Contemporary h3n2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
10.1073/pnas.1712377114 · 2017 · External reference
